Journal of Clinical Pharmacology

Pharmacokinetic Characterization of Iopamidol and Iohexol for Optimizing Measured Glomerular Filtration Rate Assessment in Clinical Practice and Drug Development.

In Vitro and Clinical Evaluations of UGT1A1-, P-gp-, OATP1B1-, and BCRP-Mediated Drug-Drug Interactions of Belumosudil, a Potent ROCK2 Inhibitor.

Belumosudil（一种强效 ROCK2 抑制剂）的 UGT1A1、P-gp、OATP1B1 和 BCRP 介导的药物相互作用的体外和临床评价

A randomized, placebo-controlled study of the pharmacokinetics, pharmacodynamics, and tolerability of the oral JAK2 inhibitor fedratinib (SAR302503) in healthy volunteers

一项关于口服 JAK2 抑制剂 fedratinib (SAR302503) 在健康志愿者中的药代动力学、药效学和耐受性的随机、安慰剂对照研究

Comparison of subcutaneous and intravenous administration of trastuzumab: a phase I/Ib trial in healthy male volunteers and patients with HER2-positive breast cancer

曲妥珠单抗皮下和静脉给药的比较：在健康男性志愿者和 HER2 阳性乳腺癌患者中进行的 I/Ib 期试验

Pharmacokinetics and pharmacodynamics of figitumumab, a monoclonal antibody targeting the insulin-like growth factor 1 receptor, in healthy participants

针对胰岛素样生长因子 1 受体的单克隆抗体 figitumumab 在健康参与者中的药代动力学和药效学

A randomized, placebo-controlled study of the effects of the p38 MAPK inhibitor SB-681323 on blood biomarkers of inflammation in COPD patients

一项关于 p38 MAPK 抑制剂 SB-681323 对 COPD 患者炎症血液生物标志物影响的随机、安慰剂对照研究

Population pharmacokinetics of belimumab following intravenous administration in patients with systemic lupus erythematosus

系统性红斑狼疮患者静脉注射贝利木单抗后的群体药代动力学

A multiple ascending dose study of CSL112, an infused formulation of ApoA-I

对 CSL112（ApoA-I 输注制剂）进行多次递增剂量研究

Effect of renal function on the pharmacokinetics of palifermin

肾功能对帕利夫明药代动力学的影响

Expression of Ceruloplasmin in the Peripheral Blood of Patients With Drug-Resistant Epilepsy

耐药性癫痫患者外周血铜蓝蛋白的表达